
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8629428
[patent_doc_number] => 08361499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 13/535996
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12805
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535996
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535996 | Controlled release hydrocodone formulations | Jun 27, 2012 | Issued |
Array
(
[id] => 9020495
[patent_doc_number] => 08530481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Stable pharmaceutical composition of freeze-dried tetrodotoxin powder'
[patent_app_type] => utility
[patent_app_number] => 13/533907
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7934
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533907 | Stable pharmaceutical composition of freeze-dried tetrodotoxin powder | Jun 25, 2012 | Issued |
Array
(
[id] => 9262226
[patent_doc_number] => 20130344155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'FENOFIBRATE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/531955
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11879
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13531955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/531955 | Fenofibrate formulation | Jun 24, 2012 | Issued |
Array
(
[id] => 15510307
[patent_doc_number] => 10561720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
[patent_app_type] => utility
[patent_app_number] => 13/531433
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 17029
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13531433
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/531433 | Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators | Jun 21, 2012 | Issued |
Array
(
[id] => 8453841
[patent_doc_number] => 20120264788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/530990
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2435
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530990
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530990 | Animal parasite-control method using insect growth regulators | Jun 21, 2012 | Issued |
Array
(
[id] => 8981646
[patent_doc_number] => 08512759
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-08-20
[patent_title] => 'Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles'
[patent_app_type] => utility
[patent_app_number] => 13/490697
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 18657
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13490697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/490697 | Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles | Jun 6, 2012 | Issued |
Array
(
[id] => 8515904
[patent_doc_number] => 20120315312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'CORE-SHELL PARTICLES WITH A HIGH CONTENT OF GLYCEROL, THEIR PRODUCTION AND USE'
[patent_app_type] => utility
[patent_app_number] => 13/490835
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3071
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13490835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/490835 | Core-shell particles with a high content of glycerol, their production and use | Jun 6, 2012 | Issued |
Array
(
[id] => 9244842
[patent_doc_number] => 08609121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Titanium dioxide photocatalytic compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/463495
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6322
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463495 | Titanium dioxide photocatalytic compositions and uses thereof | May 2, 2012 | Issued |
Array
(
[id] => 8807354
[patent_doc_number] => 08445003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Stable pharmaceutical composition and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 13/458496
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 16143
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458496
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458496 | Stable pharmaceutical composition and methods of using same | Apr 26, 2012 | Issued |
Array
(
[id] => 9081084
[patent_doc_number] => 20130266614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'LIPID CARRIER FOR DELIVERY OF BIOACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/443455
[patent_app_country] => US
[patent_app_date] => 2012-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5134
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13443455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/443455 | LIPID CARRIER FOR DELIVERY OF BIOACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION | Apr 9, 2012 | Abandoned |
Array
(
[id] => 8482894
[patent_doc_number] => 20120282301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'POROUS CALCIUM PHOSPHATE BONE MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/438207
[patent_app_country] => US
[patent_app_date] => 2012-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14602
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438207
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438207 | Porous calcium phosphate bone material | Apr 2, 2012 | Issued |
Array
(
[id] => 8426108
[patent_doc_number] => 20120247982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'STABILIZED PHARMACEUTICAL PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 13/437569
[patent_app_country] => US
[patent_app_date] => 2012-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11404
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/437569 | Stabilized pharmaceutical product | Apr 1, 2012 | Issued |
Array
(
[id] => 8429724
[patent_doc_number] => 20120251599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'MAKEUP COMPOSITION COMPRISING ENCAPSULATED CARBON BLACK'
[patent_app_type] => utility
[patent_app_number] => 13/429895
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4120
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429895
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/429895 | Makeup composition comprising encapsulated carbon black | Mar 25, 2012 | Issued |
Array
(
[id] => 8277389
[patent_doc_number] => 20120171259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/408133
[patent_app_country] => US
[patent_app_date] => 2012-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8789
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13408133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/408133 | ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION | Feb 28, 2012 | Abandoned |
Array
(
[id] => 8482891
[patent_doc_number] => 20120282298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/368580
[patent_app_country] => US
[patent_app_date] => 2012-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 40412
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13368580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/368580 | CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN | Feb 7, 2012 | Abandoned |
Array
(
[id] => 8221855
[patent_doc_number] => 20120136060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'IMMEDIATE RELEASE AND SUSTAINED RELEASE IBUPROFEN DOSING REGIMEN'
[patent_app_type] => utility
[patent_app_number] => 13/367504
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5311
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367504
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/367504 | Immediate release and sustained release ibuprofen dosing regimen | Feb 6, 2012 | Issued |
Array
(
[id] => 10592949
[patent_doc_number] => 09314016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Rodent control device'
[patent_app_type] => utility
[patent_app_number] => 14/374608
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5836
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374608
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374608 | Rodent control device | Jan 26, 2012 | Issued |
Array
(
[id] => 9792263
[patent_doc_number] => 20150004207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'INTERVENTIONAL MEDICAL DEVICE AND MANUFACTURING METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/348815
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2754
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348815
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348815 | INTERVENTIONAL MEDICAL DEVICE AND MANUFACTURING METHOD THEREOF | Jan 16, 2012 | Abandoned |
Array
(
[id] => 8865640
[patent_doc_number] => 20130149343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'Hemostatic Bioabsorbable Device with Polyethylene Glycol Binder'
[patent_app_type] => utility
[patent_app_number] => 13/324115
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5678
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324115
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324115 | Hemostatic bioabsorbable device with polyethylene glycol binder | Dec 12, 2011 | Issued |
Array
(
[id] => 8095731
[patent_doc_number] => 20120083480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'CONTROLLED RELEASE DELIVERY SYSTEM FOR NASAL APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/316494
[patent_app_country] => US
[patent_app_date] => 2011-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3030
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083480.pdf
[firstpage_image] =>[orig_patent_app_number] => 13316494
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/316494 | Controlled release delivery system for nasal applications | Dec 9, 2011 | Issued |